Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04271631
Other study ID # PS001
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 12, 2019
Est. completion date May 31, 2020

Study information

Verified date February 2020
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diabetes mellitus is increasing in incidence worldwide. The goal of management of diabetes is to achieve blood sugar control by minimizing side effects and preventing short and long term complications. Self-management becomes important in the management of diabetes mellitus. The use of mobile phone applications provides opportunities for the management of diabetics. In addition, health coaching is one of method used for empowering patients with chronic diseases, such as diabetes. This study aims to evaluate the impact of Mobile Application-Based Diabetes Education and health coaching in management of type 2 diabetes mellitus.


Description:

A randomized control trial, pre and post study involving 105 subjects randomized into 3 arms:

- Control : received conventional education group

- Intervention 1 : received conventional education group + mobile application-based diabetes education

- Intervention 2 : received mobile application-based diabetes education + health coaching

Conventional education group divided into 6 session, which for each session consist of 2 different topics and lasts for 60 minutes.

Mobile application-based diabetes education is using DM Educorner (Diabetes Mellitus Education Corner) availablle in Google PlayStore. Education contents was delivered in articles, video and infographics.

Health coaching was given by a coach, a healthcare professional who undergo training to become a coach. Health coaching delivered as face to face between subjects and coach.

Laboratory examination and questionnaire collected at baseline, 3 and 6 months after intervention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 105
Est. completion date May 31, 2020
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria:

- Type 2 Diabetes Mellitus

- multiple daily insulin injection (basal and rapid, or mixed)

- 30 - 65 years old

- HbA1c > 8%

- Using smartphone in daily lives.

- Willing to follow the research by signing an informed consent

Exclusion Criteria:

- Patients with cognitive disease (such as dementia)

- Patients with hearing or sight problem

- Unable to live independently on daily basis

- Patients who have disease that may affect Hba1c such as hemolytic anemia, thalassemia

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mobile Application-Based Diabetes Education
Additional education was given using application, subjects were asked to open the application at least once a day
Health Coaching
Health coaching was given as face to face with a coach

Locations

Country Name City State
Indonesia Faculty of Medicine, Universitas Indonesia Jakarta Pusat DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Hb1A1c at 3 months Glycemic control 3 months
Secondary Change from Baseline Fasting plasma glucose at 3 months Glycemic control 3 months after intervention
Secondary Change from Baseline 2 hours-post prandial plasma glucose at 3 months Glycemic control 3 months after intervention
Secondary Change from Baseline Total cholesterol at 3 months Diabetes Mellitus control 3 months after intervention
Secondary Change from Baseline High-density lipoprotein cholesterol (HDL-c) at 3 months Diabetes Mellitus control 3 months after intervention
Secondary Change from Baseline Low-density lipoprotein cholesterol (LDL-c) at 3 months Diabetes Mellitus control 3 months after intervention
Secondary Change from Baseline Triglycerides at 3 months Diabetes Mellitus control 3 months after intervention
Secondary Mean of intake calories from food Record mean calorief from diet intake in 3 days at baseline, 3 months after intervention
Secondary Global Physical Activities Questionnaire Questionnaire about physical activities in whole one week. Divided into 3 categories: low, moderate, high. Every categories describe duration and numbers of day being active during 1 weeks and not for judging it is good or worse. at baseline, 3 and 6 months after intervention
Secondary Self-Monitoring Blood Glucose Notes of daily blood glucose through study completion, an average of 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2